<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Today, we are witnessing a rising incidence of <z:hpo ids='HP_0001513'>obesity</z:hpo> worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>This increase is due to a sedentary life style, an increased caloric intake and a decrease in physical activity </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001513'>Obesity</z:hpo> contributes to the appearance of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> and cardiovascular complications due to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, and <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, the development of new therapeutic strategies may become a necessity </plain></SENT>
<SENT sid="4" pm="."><plain>Given the metabolism controlling properties of nuclear receptors in peripheral organs (such as liver, adipose tissues, pancreas) and their implication in various processes underlying <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic diseases</z:e>, they constitute interesting therapeutic targets for <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The recent identification of the central <z:mp ids='MP_0008912'>nervous</z:mp> system as a player in the control of peripheral metabolism opens new avenues to our understanding of the pathophysiology of <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and potential novel ways to treat these diseases </plain></SENT>
<SENT sid="6" pm="."><plain>While the metabolic functions of nuclear receptors in peripheral organs have been extensively investigated, little is known about their functions in the brain, in particular with respect to brain control of energy homeostasis </plain></SENT>
<SENT sid="7" pm="."><plain>This review provides an overview of the relationships between nuclear receptors in the brain, mainly at the hypothalamic level, and the central regulation of energy homeostasis </plain></SENT>
<SENT sid="8" pm="."><plain>In this context, we will particularly focus on the role of PPARα, PPARγ, LXR and Rev-erbα </plain></SENT>
</text></document>